ACTICOAT◊ FLEX Antimicrobial Barrier Dressings

Combines nanocrystalline silver (NCS) technology with a flexible low-adherent layer to conform to body contours, delivering a sustained antimicrobial action for up to 7 days*1-5

ACTICOAT-FLEX-HERO-840x840-PX.png

Your complete solution

See how S+N will be with you every step of the way in implementing!@#$%^&*() change.

See how S+N will be with you every step of the way in implementing change.

  • See how S+N will be with you every step of the way in implementing change.

  1. See how S+N will be with you every step of the way in implementing change.

See how S+N will be with you every step of the way in implementing change.
See how S+N will be with you every step of the way in implementing change.

Titel

Titel

Titel

Titel
Titel
4-ACTICOAT-FLEX-GLOBAL-840x840.png

Product feature

Reference Materials

Responding to the needs of wound care clinicians and their patients, we’ve reinvented our flagship foam dressing technology to deliver a new, versatile solution designed to offer COMPLETE CARE.

Built to help defend patients against factors that contribute to pressure injuries*1-4 and helps minimise exudate leakage**5-7 with a next-generation, five-layer construction.

+ For pressure injury prevention:

Using ShearDEFENSE◊ Technology, ALLEVYN COMPLETE CARE Dressings absorb shear forces and reduce soft tissue strain to help minimise the risk of pressure injuries,*1,8,9 as part of a suitable prevention protocol1,8,9

+ For exudate management:

Highly effective in absorbing and locking away low-high levels of exudate and bacteria, even under compression, including normal and viscous exudate.5,10-12 Shown to help manage bioburden**10,11,13 and minimise leakage5-7

Evidence and Case Studies

Medical Education

No results.

Disclaimer

*Depending on dressing selection. ACTICOAT FLEX 3 offers up to 3 days’ use. ACTICOAT FLEX 7 offers up to 7 days’ use.

**As demonstrated in vitro.

Citations

1. Smith+Nephew 2011. Internal report. SR/CE/036/ACB.

2. Smith+Nephew 2008. Internal report. DOF 0810016.

3. Smith+Nephew 2008. Internal report. DOF 0810017.

4. Smith+Nephew 2008. Internal report. DOF 0810012.

5. Smith+Nephew 2008. Internal report. DOF 0810013.

6. Smith+Nephew. A 17-Day wound healing study in full-thickness wounds in minipigs. Internal Statement.

7. Wright JB, et al. Am J Infect Control. 1998;26(6):572 - 577.

8. Wright JB, et al. Am J Infect Control. 1999;27(4):344 - 350.

9. Smith+Nephew 2017. Internal report. DS/16/363/R2.

10. Westaim Biomedical 2001. Internal report - 971030.

11. Smith+Nephew 2008. Internal report. DS/08/123/R1.

12. Cuttle L, et al. Burns. 2007;33(6):701 - 707.

13. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.001.v2.

14. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.002.v2.

15. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.

16. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.004.v2.

17. Gago M, et al. Wounds. 2008;20(10):273 - 278.

18. Demling RH, et al. Burns. 2002;28(3):264 - 266

19. Smith+Nephew 2008. Internal report. DOF 0810018.

20. Smith+Nephew 2008. Internal report. DOF 0810014.

21. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200.

22. Wright JB, et al. Wounds. 1998;10(6):179 - 188.

23. Smith+Nephew 2008. Internal report. DS/08/062/R1.

24. Westaim Biomedical 2000. Internal report - 001213.

25. Westaim Biomedical 2001. Internal report - 010322.

26. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.

Title

Text

Explore